Paul L Wood1. 1. Metabolomics Unit, Dept. of Physiology and Pharmacology, DeBusk College of Osteopathic Medicine, Lincoln Memorial University, 6965 Cumberland Gap Pkwy, Harrogate, TN.
Abstract
BACKGROUND: While schizophrenia is generally considered a neurodevelopment disorder, our basic understanding of the biochemical processes involved in disease etiology and/or progression is limited. One class of biochemical mediators that has been suggested to play a role in the development of schizophrenia is N-acyl ethanolamine metabolites of N-acylphosphatidylethanolamines. However, no investigations of N-acylphosphatidylserines or their N-acylserine metabolites have been published. METHODS: We undertook a targeted postmortem lipidomics analysis of N-acylphosphatidylserines (NAPS) and N-acylserines (NAS) in gray matter of the frontal cortex of schizophrenia subjects. RESULTS: Our data are the first to demonstrate that NAPS and NAS are present in human brain. Furthermore, NAPS and their bioactive metabolites, N-acylserines (NAS), were found to be significantly elevated in the frontal cortex of schizophrenia subjects. CONCLUSIONS: Elevated levels of NAPS lipid pools in schizophrenia may result in complex alterations in the structural function of neuronal membranes while increases in NAS may alter signal transduction pathways.
pan class="abstract_title">BACKGROUND: While schizophrenia is generally considered a neurodevelopment disorder, our basic understanding of the biochemical processes involved in disease etiology and/or progression is limited. One class of biochemical mediators that has been suggested to play a role in the development of schizophrenia is N-acyl ethanolamine metabolites of N-acylphosphatidylethanolamines. However, no investigations of N-acylphosphatidylserines or their N-acylserine metabolites have been published. METHODS: We undertook a targeted postmortem lipidomics analysis of N-acylphosphatidylserines (NAPS) and N-acylserines (NAS) in gray matter of the frontal cortex of schizophrenia subjects. RESULTS: Our data are the first to demonstrate that NAPS and NAS are present in human brain. Furthermore, NAPS and their bioactive metabolites, N-acylserines (NAS), were found to be significantly elevated in the frontal cortex of schizophrenia subjects. CONCLUSIONS: Elevated levels of NAPSlipid pools in schizophrenia may result in complex alterations in the structural function of neuronal membranes while increases in NAS may alter signal transduction pathways.
Authors: Dmitri Tkachev; Michael L Mimmack; Stephen J Huffaker; Margaret Ryan; Sabine Bahn Journal: Int J Neuropsychopharmacol Date: 2007-02-12 Impact factor: 5.176
Authors: Kenneth L Davis; Daniel G Stewart; Joseph I Friedman; Monte Buchsbaum; Philip D Harvey; Patrick R Hof; Joseph Buxbaum; Vahram Haroutunian Journal: Arch Gen Psychiatry Date: 2003-05
Authors: Matilda Degn; Kate L Lambertsen; Gitte Petersen; Michael Meldgaard; Andreas Artmann; Bettina H Clausen; Steen H Hansen; Bente Finsen; Harald S Hansen; Trine M Lund Journal: J Neurochem Date: 2007-09-14 Impact factor: 5.372
Authors: Ralf Brisch; Arthur Saniotis; Rainer Wolf; Hendrik Bielau; Hans-Gert Bernstein; Johann Steiner; Bernhard Bogerts; Katharina Braun; Anna Katharina Braun; Zbigniew Jankowski; Jaliya Kumaratilake; Jaliya Kumaritlake; Maciej Henneberg; Tomasz Gos Journal: Front Psychiatry Date: 2014-05-19 Impact factor: 4.157
Authors: Rohini Sidhu; Yawo Mondjinou; Mingxing Qian; Haowei Song; Arun Babu Kumar; Xinying Hong; Fong-Fu Hsu; Dennis J Dietzen; Nicole M Yanjanin; Forbes D Porter; Elizabeth Berry-Kravis; Charles H Vite; Michael H Gelb; Jean E Schaffer; Daniel S Ory; Xuntian Jiang Journal: J Lipid Res Date: 2019-06-14 Impact factor: 5.922
Authors: Paul L Wood; Srikanth Medicherla; Naveen Sheikh; Bradley Terry; Aaron Phillipps; Jeffrey A Kaye; Joseph F Quinn; Randall L Woltjer Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472